Ascites in patients with gastric cancer;Wodobrzusze u chorych z rakiem żoładka

Onkologia Polska

Volumn 10, Issue 1, 2007, Pages 19-23

  Wroński, Konrad ^a,b   Płuzański, Adam ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Regionalny Ośrodek Onkologiczny ^*  (Poland)

Author keywords

Ascites; Gastric cancer; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DIURETIC AGENT; FLUOROURACIL; MITOMYCIN C; PACLITAXEL; SPIRONOLACTONE; TEGAFUR; TS 1; UNCLASSIFIED DRUG;

ASCITES; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER STAGING; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; HUMAN; HYPERTHERMIC THERAPY; MONOTHERAPY; PARACENTESIS; PERITONEUM VEIN SHUNT; PREOPERATIVE CARE; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK REDUCTION; STOMACH CANCER;

EID: 34249824934     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Plummer M., Franceschi S., Munoz N.: Epidemiology of gastric cancer. IARC Sci. Publ. 2004, 157, 311-326.
2. Parmo J.C., Gomez G.: Dynamic CT in the preoperative evaluation of patients with gastric cancer: correlation with surgical findings and pathology. Ann. Surg. Oncol. 1999, 6, 379-384.
3. D'Elia F., Zingarelli A., Palli D. i wsp.: Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur. Radiol. 2000, 10, 1877-1885.
4. Adachi Y., Sakino I., Matsumata T. i wsp.: Preoperative assessment of advanced gastric carcinoma using computed tomography. Am. J. Gastroenterol. 1997, 92, 872-875.
5. Kayaalp C., Arda K., Orug T. i wsp.: Value of computed tomography in additional to ulatrsound for preoperative staging of gastric cancer. Eur. J. Surg. Oncol. 2002, 28, 540-543.
6. Stell D.A., Carter C.R., Stewart I. i wsp.: Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br. J. Surg. 1996, 83, 1260-1262.
7. Nozoe T., Matsumata T., Sugimachi K.: Usefulness of preoperative transvaginal ultrasonography for women with advanced gastric carcinoma. Am. J. Gastroenterol. 1999, 94, 2509-2512.
8. Dong K.C., Ji W.K., Bvung K.K. i wsp.: Clinical significance of CT-defined minimal ascites in patients with gastric cancer. World J. Gastroenterol. 2005, 42, 6587-6592.
9. Adam R.A., Adam Y.G.: Malignant ascites: past, present, and future. J. Am. Coll. Surg. 2004, 198, 999-1011.
10. Kodera Y., Nakanishi H., Yamamura Y. i wsp.: Prognostic value and clinical implication of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int. J. Cancer 1998, 79, 429-433.
11. Doust B.D.: The use of ultrasound in the diagnosis of gastroenterological disease. Gastroenterology 1976, 70, 602-610.
12. Habermann C.R., Weiss F., Riecken R. i wsp.: Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 2004, 230, 465-471.
13. Becker G., Galandi D., Blum H.E.: Malignant ascites: systematic review and guideline for treatment. Eur. J. Cancer 2006, 42, 589-597.
14. Gough I.R., Balderson G.A.: Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management. Cancer 1993, 71, 2377-2382.
15. Pockros P.J., Esrason K.T., Nguyen C. i wsp.: Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology 1992, 103, 1302-1306.
16. Greenway B., Johnson P.J., Williams R.: Control of malignant ascites with spironolactone. Br. J. Surg. 1982, 69, 441-442.
17. McNamara P.: Paracentesis - an effective method of symptom control in the palliative care setting? Palliat. Med. 2000, 14, 62-64.
18. Gines P., Cardenas A., Arroyo V. i wsp.: Management of cirrhosis and ascites. N. Engl. J. Med. 2004, 350, 1646-1654.
19. Ross G.J., Kessler H.B., Clair M.R. i wsp.: Sonographically guided paracentesis for palliation of symptomatic malignant ascites. Am. J. Roentgenol. 1989, 153, 1309-1311.
20. Yan T.D., Black D., Savady R. i wsp.: Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J. Clin. Oncol. 2006, 24, 4011-4019.
21. Kunisaki C., Shimada H., Akiyama H. i wsp.: Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 2006, 53, 473-478.
22. Howell S.B., Pfeifle C.L., Wung W.E. i wsp.: Intraperitoneal cisplatin with systemic thiosulfate protection. Ann. Intern. Med. 1982, 97, 845-851.
23. Markman M., Rowinsky E., Hakes T. i wsp.: Phase 1 trial of intraperitoneal taxol: a Gynecoloic Oncology Group study. J. Clin. Oncol. 1992, 10, 1485-1491.
24. Rowinsky E.K., Donehower R.C.: Paclitaxel (taxol). N. Engl. J. Med. 1995, 332, 1004-1014.
25. Lopez J.A., Krikorian J.G., Reich S.D. i wsp.: Clinical pharmacology of intraperitoneal cisplatin. Gynecol. Oncol. 1985, 20, 1-9.
26. Schneider J.G.: Intraperitoneal chemotherapy. Obstet. Gynecol. Clin. North Am. 1994, 21, 195-212.
27. Francis P., Rowinsky E., Schneider J. i wsp.: Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study. J. Clin. Oncol. 1995, 13, 2961-2967.
28. Kunisaki C., Shimada H., Nomura M. i wsp.: Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery 2002, 131, 521-528.
29. Urano M., Kuroda M., Nishimura Y.: For the clinical application of thermochemotherapy given at mild temperatures. Int. J. Hyperthermia 1999, 15, 79-107.
30. Beaujard A.C., Glehen O., Caillot J.L. i wsp.: Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000, 88, 2512-2519.
31. Fujimoto S., Takahashi M., Kobayashi K. i wsp.: Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992, 70, 2754-2760.
32. Yajima K., Kanda T., Ohashi M. i wsp.: Clinical and diagnostic significance of preoperative computed tomography findings of ascites in patients with advanced gastric cancer. Am. J. Surg. 2006, 192, 185-190.
33. Toyokawa T., Sawada T., Muguruma K. i wsp.: A case of advanced gastric cancer with malignant ascites responding to weekly paclitaxel therapy. Gan. To Kagaku Ryoho. 2006, 33, 1637-1640.
34. Imamura H., Furukawa H., Kishimoto T. i wsp.: A case of complete remission of carcinomatous ascites refractory for TS- 1 monotherapy treated with TS-1 plus paclitaxel combined therapy for gastric cancer. Gan. To Kagaku Ryoho. 2006, 33, 1900-1903.
35. Sugihara S., Ikuta Y., Kobayashi H. i wsp.: Effective TS-1 + paclitaxel administration for gastric cancer with malignant ascites. Gan To Kagaku Ryoho 2005, 32, 2109-2111.
36. Ohtani S., Shimizu Y., Sugiyama S. i wsp.: A case of advanced gastric cancer with carcinomatous ascites successfully treated by outpatient chemotherapy. Gan To Kagaku Ryoho 2007, 34, 85-87.
37. Ayantunde A., Parsons S.: Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann. Oncol. 2007, 13, 32-35.
38. Pollock A.V.: The treatment of resistant malignant ascites by insertion of a peritoneo-atrial Hotter valve. Br. J. Surg. 1975, 62, 104-107.
39. Allon M., Soucie J.M., Macon E.J.: Complications of peritoneal dialysis catheters: experience with 154 percutaneously placed catheters. Nephrologie 1988, 48, 8-11.
40. Gough I. R.: Control of malignant ascites by peritoneovenous shunting. Cancer 1984, 54, 2226-2230.
41. Faught W., Kirkpatrick J.R., Krepart G.V. i wsp.: Peritoneovenous shunt for palliation of gynecologic malignant ascites. J. Am. Coll. Surg. 1995, 180, 472-474.
42. Souter R.G., Train D., Kettlewell M.G.: Peritoneovenous shunts in the malignant ascites. Br. J. Surg. 1983, 70, 478-481.
43. Jacobs I.G., Gray R.R., Elliott D.S. i wsp.: Radiologic placement of peritoneal dialysis catheters: preliminary experience. Radiology 1992, 182, 251-255.
44. Savender S.J.: Precutaneous radiologic placement of peritoneal dialysis catheters. J. Vasc. Interv. Radiol. 1999, 10, 249-256.
45. Lorentzen T., Sengelov L., Nolsoe C.P. i wsp.: Ultrasonically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol. 1995, 36, 481-484.
46. O'Neill M.J., Weissleder R., Gervais D.A. i wsp.: Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. Am. J. Radiol. 2001, 177, 615-618.
47. Savin M.A., Kirsch M.J., Romano W.J. i wsp.: Peritoneal ports for treatment of intractable ascites. J. Vasc. Interv. Radiol. 2005, 16, 363-368.
48. Barnett T.D., Rubins J.: Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified precutaneous approach. J. Vasc. Interv. Radiol. 2002, 13, 379-383.